Aptadir Therapeutics unveils promising RNA inhibitors to combat cancer and genetic diseases
Aptadir Therapeutics, a biotechnology startup based in Italy, has made a noteworthy entry into the pharmaceutical landscape with the launch of a groundbreaking class of …